Safety first
Guide / Research briefs

Indoor Tanning and Melanoma: Key Numbers from Long-Term Cohort Data

Published October 28, 2026 · MTI Editorial Team · Sources linked on this page

!
Educational information only. Not medical advice and no dosing information. Melanotan I and II sold online are not FDA-approved. Talk to a licensed doctor.
Indoor Tanning and Melanoma: Key Numbers from Long-Term Cohort Data
Photo: "Indoor-tanning goggles (2016)" by SarahSV, CC BY 4.0, via Wikimedia Commons (cropped).

Discussions regarding artificial tanning frequently turn to questions about actual risk. While public health messaging has long discouraged tanning lamps, much of the early scientific background rested on retrospective case-control research, where participants were asked to recall past habits after already receiving a diagnosis. To better evaluate this relationship over time, researchers turned to prospective population data. A major paper published in the American Journal of Epidemiology, titled Indoor Tanning and Melanoma Risk: Long-Term Evidence From a Prospective Population-Based Cohort Study, tracked tanning device use across an extensive timeline. Below is a breakdown of the critical figures established in this single investigation.

141,045 Participants Followed for an Average of 13.7 Years

The investigation utilized data from the Norwegian Women and Cancer Study, a large prospective population-based cohort. Rather than surveying patients after an illness appeared, the design followed healthy individuals forward through time. The scale of the dataset includes several central parameters:

  • 141,045 women were enrolled and monitored as part of the primary analysis cohort.
  • Follow-up spanned the calendar years from 1991 through 2012.
  • The mean duration of follow-up was 13.7 years per participant.
  • A total of 861 women received a verified diagnosis of melanoma during the follow-up window.

Because the exposure information was documented as the study progressed, this structure reduced certain recall biases inherent to retrospective surveys. Readers learning about ultraviolet radiation and skin health can consult our guide on tanning beds and UV risk to explore how artificial bulbs compare to outdoor exposure.

1.32 Relative Risk: The Dose-Response Association

To evaluate whether increased use correlated with higher disease rates, the investigators applied Poisson regression models to estimate relative risks. Participants were grouped into tiers based on their cumulative number of indoor tanning sessions across their lives. When researchers compared individuals in the highest tertile of device use against those who reported never using tanning equipment, they observed an adjusted relative risk of 1.32 (with a 95% confidence interval of 1.08 to 1.63).

Furthermore, the statistical trend across categories yielded a P-trend value of 0.006. In epidemiology, a statistically significant trend across increasing exposure categories provides evidence of a dose-response relationship, indicating that cumulative exposure matters over time.

1.31 Relative Risk for Initiation Prior to Age 30

The investigators also isolated the age at which participants first used an indoor tanning device. The data demonstrated that timing plays an important role in overall vulnerability:

  • Women who began indoor tanning before 30 years of age had an adjusted relative risk of 1.31 compared to never users.
  • The 95% confidence interval for this younger-initiation cohort was 1.07 to 1.59.

This finding supported the researchers' hypothesis that biological vulnerability to the damaging aspects of artificial ultraviolet radiation is heightened during younger years. Anyone concerned about skin changes, abnormal growths, or previous sunbed use should schedule a formal evaluation with a dermatologist or primary care doctor. Understanding how different skin lesions present is detailed in our overview of types of skin cancer.

2.2 Years Younger at Diagnosis

In addition to measuring the likelihood of developing disease, the study examined whether indoor tanning shifted the timeline of when malignancy appeared. Using linear regression to assess age of initiation relative to age at diagnosis, the authors found that women who initiated tanning device use before reaching 30 years of age were, on average, 2.2 years younger when diagnosed with melanoma compared to participants who had never used indoor tanning devices (95% confidence interval: 0.9 to 3.4 years).

This shift indicates that the consequences of artificial exposure may not merely increase overall lifetime probability, but can also advance the clinical onset of the disease to an earlier period in adulthood.

Study Design, Context, and Boundaries

When evaluating scientific literature, it is essential to consider the precise boundaries of any single report. The paper examined here, Indoor Tanning and Melanoma Risk: Long-Term Evidence From a Prospective Population-Based Cohort Study, offers the advantage of prospective tracking over a multi-decade window, avoiding many retrospective pitfalls. However, several specific limits apply:

  • The population was limited entirely to women living in Norway, meaning the findings reflect a specific geographic and demographic sample.
  • Tanning habits and session counts relied on self-reported questionnaire metrics rather than machine-logged records.
  • Because it is an observational cohort rather than an experimental intervention, unmeasured confounding variables can influence statistical models despite adjustments.

While this single study provides robust prospective documentation of dose-response relationships and early-age risks, individuals navigating questions about tanning or skin checks should always rely on personalized medical guidance from qualified healthcare professionals.

Sources

Indoor Tanning and Melanoma Risk: Long-Term Evidence From a Prospective Population-Based Cohort Study. — American Journal of Epidemiology / PubMed

Published October 28, 2026. Sources are linked in the text. See our Medical Disclaimer.